SIBO, Dysbiosis & Organic Acids Test (OAT)

Navigation & Literature

• Parent Silo: 03 - Diagnostics & Quantified Self MOC
• Literature Dossier: SIBO, Dysbiosis & Organic Acids Test (OAT) - References

---

1. Diagnostic Reference Range Comparison (3-Gas Breath Test & Urinary OAT)

Diagnostic Marker / Metabolite	Standard Clinical Cutoff	Longevity / Functional Optimal	Primary Unit	Microbial Source & Pathophysiological Mechanism
Breath Hydrogen (${\text{H}}_2$, $\le 90\text{ min}$)	Rise $<20\text{ ppm}$ over baseline	Rise $<12–15\text{ ppm}$ by $90\text{ min}$	$\text{ppm}$	Small-intestinal fermentation by Escherichia coli & Klebsiella pneumoniae (Diarrhea-predominant SIBO)
Breath Methane (${\text{CH}}_4$, Any Timepoint)	$<10\text{ ppm}$	$<3.0–5.0\text{ ppm}$	$\text{ppm}$	Intestinal Methanogen Overgrowth (IMO: Methanobrevibacter smithii); slows motility by 59%
Breath Hydrogen Sulfide (${\text{H}}_2\text{S}$, Any Timepoint)	$<3.0\text{ ppm}$	$<1.5\text{ ppm}$	$\text{ppm}$	Sulfate-reducing bacteria (Fusobacterium, Desulfovibrio); inhibits cytochrome c oxidase
OAT: D-Arabinitol / Arabinose	$<29–45\text{ mmol/mol Cr}$	$<15–20\text{ mmol/mol Cr}$	$\text{mmol/mol Cr}$	Invasive Candida albicans hyphal sugar alcohol metabolite (SIFO / Fungal Overgrowth)
OAT: HPHPA & 4-Cresol	$<150\text{ / }<50\text{ mmol/mol Cr}$	$<60\text{ / }<20\text{ mmol/mol Cr}$	$\text{mmol/mol Cr}$	Clostridia spp. tyrosine metabolites that irreversibly inhibit Dopamine $\beta$-Hydroxylase (DBH)
OAT: Indican (Indoxyl Sulfate)	$<40\text{ mg/g Cr}$	$<15\text{ mg/g Cr}$	$\text{mg/g Cr}$	Small-intestinal bacterial tryptophan putrefaction and uremic vascular toxin
OAT: Oxalate / Glycerate / Glycolate	$<35–45\text{ mmol/mol Cr}$	$<20\text{ mmol/mol Cr}$	$\text{mmol/mol Cr}$	Dietary hyperoxaluria, Oxalobacter formigenes loss, Aspergillus/Candida synthesis, or B6 deficit
Fecal $\beta$-Glucuronidase	$<2,486\text{ U/g}$	$500–1,400\text{ U/g}$	$\text{U/g}$	Bacterial estrobolome enzyme that deconjugates glucuronidated estrogens & xenobiotics for reabsorption

---

2. Physiological Significance & Mechanistic Architecture

Three-Gas Breath Testing (${\text{H}}_2$, ${\text{CH}}_4$, ${\text{H}}_2\text{S}$): SIBO vs. IMO

Whereas the colon contains $10^{11}\text{ CFU/mL}$ of bacteria, the healthy duodenum and jejunum contain $<10^3\text{ CFU/mL}$ due to gastric acid, pancreaticobiliary secretions, and the Migrating Motor Complex (MMC)—peristaltic Phase III housekeeping waves triggered every 90–120 minutes during fasting by interstitial cells of Cajal (ICC) and motilin.

• Post-Infectious Autoimmunity (Anti-CdtB & Anti-Vinculin): Acute gastroenteritis (Campylobacter, Salmonella, E. coli, Shigella) secretes Cytolethal Distending Toxin B (CdtB). Host antibodies against CdtB cross-react via molecular mimicry with vinculin on enteric interstitial cells of Cajal, paralyzing the fasting MMC and causing Small Intestinal Bacterial Overgrowth (SIBO).
• Why 3-Gas Testing is Mandatory: Historically, 2-gas breath tests (${\text{H}}_2+{\text{CH}}_4$) missed Hydrogen Sulfide (${\text{H}}_2\text{S}$) SIBO, presenting as a falsely “flatline” test because ${\text{H}}_2\text{S}$-producing bacteria (Desulfovibrio, Fusobacterium) consume $4\text{ moles}$ of ${\text{H}}_2$ gas to generate $1\text{ mole}$ of ${\text{H}}_2\text{S}$. Similarly, archaea (Methanobrevibacter smithii) consume $4\text{ moles}$ of ${\text{H}}_2$ to form $1\text{ mole}$ of Methane (${\text{CH}}_4$); methane acts as a gasotransmitter that directly activates cholinergic neurons to slow intestinal transit and cause constipation (IMO).

Urinary Organic Acids Test (OAT): Neurochemical & Mitochondrial Interference

The Urinary Organic Acids Test quantifies water-soluble metabolic intermediates excreted in morning urine:

1. Clostridia Neurotoxins (HPHPA & 4-Cresol): Pathogenic Clostridia species (C. difficile, C. sporogenes) convert dietary phenylalanine and tyrosine into HPHPA [3-(3-hydroxyphenyl)-3-hydroxypropionic acid] and 4-cresol. Both compounds covalently inhibit Dopamine $\beta$-Hydroxylase (DBH)—the copper- and Vitamin C-dependent enzyme that converts Dopamine $\to$ Norepinephrine. This causes synaptic dopamine overload (elevating urinary HVA [homovanillic acid] relative to VMA [vanillylmandelic acid], raising the $\text{HVA:VMA ratio}$) alongside norepinephrine depletion, driving brain fog, autonomic orthostatic intolerance, agitation, and oxidative neurotoxicity.
2. Fungal Metabolites (D-Arabinitol, Tartaric Acid, Ochratoxin): D-Arabinitol is a five-carbon sugar alcohol uniquely produced by invasive Candida species; elevated urinary D-arabinitol-to-creatinine ratios reliably detect Small Intestinal Fungal Overgrowth (SIFO), which often co-occurs with or follows antibiotic SIBO therapy.
3. Krebs Cycle & Mitochondrial Blocks: Elevations in succinate, fumarate, malate, $\alpha$-ketoglutarate, lactate, or ethylmalonate reveal functional bottlenecks in Complex I–II or carnitine/CoQ10/riboflavin/B-complex cofactor availability (see Mitochondrial Energetics).

Fecal $\beta$-Glucuronidase & The Estrobolome

Hepatic Phase II detoxification conjugates estrogens, BPA, and carcinogens with glucuronic acid via UGT enzymes for biliary excretion into the stool. When dysbiotic bacteria (Bacteroides, Escherichia, Clostridium) overexpress $\beta$-glucuronidase ($>2,000\text{ U/g}$), they cleave off the glucuronide group in the gut lumen, causing enterohepatic recirculation of active estrogens and xenobiotics.

---

3. Root Causes of SIBO, SIFO & OAT Dysregulation

• Impaired Migrating Motor Complex (MMC): Constant grazing/snacking (eating every 2–3 hours inhibits motilin and Phase III MMC waves), hypothyroidism (Thyroid Panel), vagal neuropathy / high sympathetic stress (Vagal Tone & HRV Regulation), and post-infectious anti-vinculin antibodies.
• Loss of Upstream Gastric & Biliary Gatekeepers: Long-term proton pump inhibitor (PPI) use, age-related hypochlorhydria, or sluggish gallbladder bile acid flow (bile acids are directly bacteriostatic in the duodenum/jejunum).

---

4. Actionable Interventions

Foundational Protocols (01 - Foundations)

• Meal Spacing for MMC Activation: Enforce 4–5 hours strictly without caloric intake between meals and a 12–14 hour overnight fast via Time-Restricted Feeding & Fasting so Phase III Migrating Motor Complex waves sweep bacteria out of the jejunum/ileum.
• Vagal Motility Stimulation: Gargling, humming, and resonance breathing before meals per Vagal Tone & HRV Regulation and Breathwork Protocols enhance dorsal motor nucleus of the vagus (DMV) cephalic-phase HCl, bile, and peristaltic signaling.

Molecular & Pharmacological Interventions (02 - Compounds & Molecules)

• Gas-Specific SIBO / IMO Eradication (Clinical & Herbal):
  • Hydrogen (${\text{H}}_2$) SIBO: Non-absorbable Rifaximin ($550\text{ mg }3\times \text{/day}$ for 14 days) paired with PHGG ($5\text{ g/day}$) (which increases Rifaximin eradication efficacy from $62\%$ to $87\%$ by keeping bacteria metabolically active), OR standardized herbal antimicrobials (Berberine $1500\text{ mg/day}$ + Oregano Oil [ADP] + Neem for 4 weeks, which matched Rifaximin in the Chedid et al. Johns Hopkins trial).
  • Methane (${\text{CH}}_4$) IMO: Rifaximin + Neomycin (or Metronidazole), OR Stabilized Allicin (Allimed $450–900\text{ mg }3\times \text{/day}$) + Berberine/Oregano + Lactobacillus reuteri DSM 17938 (which lowers luminal ${\text{H}}_2$ availability to methanogens).
  • Hydrogen Sulfide (${\text{H}}_2\text{S}$) SIBO: Bismuth subsalicylate/subnitrate ($500\text{ mg }3–4\times \text{/day}$ for 14 days to bind ${\text{H}}_2\text{S}$) + Oregano oil + Molybdenum ($150–300\mu \text{g/day}$ to support sulfite oxidaseSUOX).
• Nocturnal Prokinetics (Mandatory Post-Eradication Relapse Prevention): Administer at bedtime (at least 3 hours after last meal) for 3–6 months: Prucalopride (Motegrity $0.5–1.0\text{ mg}$, a selective $5{\text{-HT}}_4$ agonist that stimulates enteric neurogenesis and MMC waves), Low-Dose Erythromycin ($50\text{ mg}$, motilin receptor agonist), or standardized Ginger (gingerols) + Artichoke leaf extract (Motility Pro).
• Estrobolome & OAT Targeted Support:
  • Calcium-D-Glucarate ($500–1000\text{ mg }2\times \text{/day}$): Directly inhibits bacterial $\beta$-glucuronidase for 5 hours, ensuring biliary clearance of conjugated estrogens and toxins.
  • Saccharomyces boulardii + Caprylic Acid / Undecylenic Acid: Eradicates Candida (lowering OAT Arabinose) and Clostridia (lowering HPHPA / 4-Cresol).

---

5. Key Scientific Evidence Summary

• Rezaie et al. (2017, American Journal of Gastroenterology) & Birg et al. (2019): North American Consensus establishing diagnostic breath-testing cutoffs ($\Delta {\text{H}}_2\ge 20\text{ ppm}$ by 90 min, ${\text{CH}}_4\ge 10\text{ ppm}$) and 4-gas validation showing ${\text{H}}_2\text{S}\ge 3\text{ ppm}$ predicts diarrhea.
• Pimentel et al. (2015, PLoS ONE): Validated anti-CdtB and anti-vinculin antibodies ($n=2,681$) as autoimmune biomarkers distinguishing post-infectious IBS/SIBO from IBD with $>90\%$ specificity.
• Chedid et al. (2014, Global Advances in Health and Medicine): Multicenter clinical trial ($n=104$) proving standardized herbal antimicrobials are at least as effective as Rifaximin ($46\%$ vs. $34\%$ breath-test normalization) and rescue 57% of Rifaximin non-responders.
• Shaw (2010, Nutritional Neuroscience): Characterized urinary HPHPA as a potent Clostridia tyrosine metabolite that inhibits dopamine $\beta$-hydroxylase and alters central catecholamine turnover.

See full bibliographic details and quantitative effect sizes in SIBO, Dysbiosis & Organic Acids Test (OAT) - References.